Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
NSUN5-CBX8 m5C axis promotes gastric tumorigenesis by activating JAK-STAT3 signaling
Jingyi Yin1, Lingmeng Li1, Yinan Niu1
1Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.
Abstract:
Emerging evidence implicates dysregulated RNA methylation in tumorigenesis across cancers. Among RNA methyltransferases, NSUN5 exhibits the highest alteration frequency in gastric cancer (GC), yet its functional and mechanistic contributions remain largely elusive. In this study, we report that Nsun5 gene depletion significantly suppressed gastric tumorigenesis in Trp53fl/fl; KrasLSL-G12D/+; Villin-Cre model mice. Wild-type Nsun5, but not its catalytically inactive mutant Nsun5C330A/C404A, largely rescued tumor formation in Nsun5-depleted Trp53-/-; KrasG12D/+ cells. Mechanistically, NSUN5 increases chromobox 8 (CBX8) protein levels by methylating and stabilizing CBX8 mRNA. As a core component of polycomb repressive complex 1 (PRC1), increased CBX8 protein expression leads to increased inhibition of the expression of SOCS2 and ultimately activates the JAK-STAT3 signaling pathway. Furthermore, the CBX8 inhibitor SW2-110A effectively antagonized Nsun5-triggered tumor formation by Trp53-/-; KrasG12D/+ GC cells. Collectively, our findings revealed how NSUN5 drives GC and revealed a promising lead compound that inhibits GC tumorigenesis.
Insights
NSUN5 RNA methylation drives gastric cancer (GC) by stabilizing CBX8 mRNA, activating JAK-STAT3 signaling. Inhibiting CBX8 with SW2-110A offers a potential therapeutic strategy for GC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Dysregulated RNA methylation is increasingly linked to cancer development.
- NSUN5 is frequently altered in gastric cancer (GC), but its role is unclear.
Purpose of the Study:
- To elucidate the functional and mechanistic role of NSUN5 in gastric tumorigenesis.
- To identify potential therapeutic targets for GC.
Main Methods:
- Utilized a Trp53; Kras; Villin-Cre mouse model for gastric tumorigenesis.
- Investigated NSUN5's catalytic activity and its effect on CBX8 mRNA stability.
- Analyzed the impact of NSUN5 on the PRC1 complex, JAK-STAT3 pathway, and SOCS2 expression.
- Tested the efficacy of a CBX8 inhibitor (SW2-110A) in a preclinical setting.
Main Results:
- Nsun5 gene depletion significantly suppressed gastric tumor formation in mice.
- Wild-type NSUN5, but not a catalytically inactive mutant, rescued tumor formation.
- NSUN5 stabilizes CBX8 mRNA, increasing CBX8 protein levels and activating the JAK-STAT3 pathway via SOCS2 inhibition.
- The CBX8 inhibitor SW2-110A effectively antagonized NSUN5-driven GC cell tumorigenesis.
Conclusions:
- NSUN5 drives gastric tumorigenesis by regulating CBX8 protein levels and activating the JAK-STAT3 signaling pathway.
- Targeting NSUN5 or its downstream effector CBX8 presents a promising therapeutic strategy for gastric cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

